http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108840794-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-255
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-255
filingDate 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108840794-B
titleOfInvention Novel curcumin drug cocrystal and preparation method thereof
abstract The invention relates to a curcumin-coniferol pharmaceutical co-crystal and a preparation method thereof. The eutectic is formed by combining curcumin and abietyl phenol through non-covalent interaction. The eutectic belongs to the triclinic system and has an axial length a =15.652~15.852Å, b =11.476~11.676Å, c =7.226~ 7.426A, axial angle α =97.37°~97.57°, β =96.29°~96.49°, γ =100.46 ° -100.66 °, eutectic in the X-ray powder diffraction pattern at diffraction angle 2 θ There are major peaks at =8.757 °, 17.142 °, 20.304 °, 22.512 °, 23.227 °, 24.614 °, 26.028 °. The co-crystals of the present invention may be prepared by a solvent-assisted milling process. The invention provides possibility for crystal modification on the premise of not changing the covalent structure of curcumin.
priorityDate 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012138907-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430895435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454062057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344

Total number of triples: 35.